Article metrics
PDF
Other content recommended for you
- Therapeutic optimism in the consent forms of phase 1 gene transfer trials: an empirical analysis
- Systematic review and metasummary of attitudes toward research in emergency medical conditions
- Assessing research risks systematically: the net risks test
- Phase 1 oncology trials and informed consent
- Are therapeutic motivation and having one's own doctor as researcher sources of therapeutic misconception?
- CD3xCD19 DART molecule treatment induces non-apoptotic killing and is efficient against high-risk chemotherapy and venetoclax-resistant chronic lymphocytic leukemia cells
- Participants’ responsibilities in clinical research
- Risk factors associated with Richter’s transformation in patients with chronic lymphocytic leukaemia: protocol for a retrospective population-based cohort study
- Phase I oncology trials: why the therapeutic misconception will not go away
- Therapeutic appropriation: a new concept in the ethics of clinical research